Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2025-07-30 | 2025-06-10 |
| Drug Identification Number | 02482126 | 02482126 |
| Brand name | NRA-DULOXETINE | NRA-DULOXETINE |
| Common or Proper name | NRA-Duloxetine | NRA-Duloxetine |
| Company Name | NORA PHARMA INC | NORA PHARMA INC |
| Ingredients | DULOXETINE | DULOXETINE |
| Strength(s) | 30MG | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | Bottle 100's | Bottle 100's |
| ATC code | N06AX | N06AX |
| ATC description | ANTIDEPRESSANTS | ANTIDEPRESSANTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2025-12-01 | 2025-12-01 |
| Actual start date | ||
| Estimated end date | Unknown | Unknown |
| Actual end date | 2025-07-29 | |
| Shortage status | Avoided shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Health Canada has issued extension for old formulation. | Shortage due to authorization of old formulation till 31st July 2025 and waiting for the approval of new formulation. |
| Health Canada comments |